SYP and congenital myasthenic syndrome: Nevertheless, synaptic markers like postsynaptic density protein 95 (PSD95) and synaptophysin protein levels were increased after 11β-HSD1 inhibition treatment, both in the control and CMS groups (Figure 7C,D).